Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023
06:59am, Thursday, 15'th Dec 2022
NEW YORK--( BUSINESS WIRE )--Bristol Myers Squibb (NYSE:BMY) will announce results for the fourth quarter of 2022 on Thursday, February 2, 2023. Company executives will review financial results and ad
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Wednesday, 14'th Dec 2022
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Paccar, Deere, and 10 More Companies That Raised Their Stock Dividends
07:00am, Saturday, 10'th Dec 2022
Southwest Airlines also said it will resume paying a dividend.
Early Q4 Earnings Results and Analyst Reports for Merck, Bristol-Myers & Deere
03:03pm, Friday, 09'th Dec 2022
Today's Research Daily features update on the Q4 earnings season and new research reports on Merck (MRK), Bristol-Myers (BMY) and Deere (DE).
Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?
11:17am, Friday, 09'th Dec 2022
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
10:32am, Friday, 02'nd Dec 2022
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Top Healthcare Stocks to Buy With $100
09:05am, Thursday, 01'st Dec 2022
Triple-digit growth and innovation go hand-in-hand with these companies.
PRO Watch DCLA's Sarat Sethi break down stocks to watch, markets
08:12am, Tuesday, 29'th Nov 2022
Sarat Sethi, managing partner and portfolio manager at DCLA, joins CNBC's 'Squawk Box' to break down potential market strategies and stocks to watch ahead of the open. Sethi also breaks down how he's
Bristol Myers Squibb: Share Price Growth In 2022 Best For A Decade - But 2023 Could Better It
07:30am, Tuesday, 29'th Nov 2022
Bristol Myers Squibb is a pharmaceutical powerhouse after its Celgene acquisition. The company's revenues in 2022 will be down slightly year-on-year as Revlimid sales fall from $12bn to ~$9bn after pa
4 Pharmaceutical Companies Among 19 To Announce Annual Dividend Increases In December
05:00am, Monday, 28'th Nov 2022
Among the 19 companies that are expected to announce annual dividend increases in December are drugmakers Eli Lilly, Pfizer, Bristol Myers Squibb, and Amgen. Investors are also waiting for Merck's inc
Bristol-Myers Squibb Is Still An Attractive Addition To Your Dividend Growth Portfolio
01:57am, Sunday, 27'th Nov 2022
Shares of Bristol-Myers Squibb Company are up 28% year to date. Bristol-Myers Squibb is still attractively valued.
3 Dividend Stocks to Hold Forever
06:05am, Saturday, 26'th Nov 2022
These businesses -- and dividends -- are built to last.
Bristol Myers (BMY) Gains 24.2% YTD: What's in Store for 2023?
01:32pm, Monday, 21'st Nov 2022
Biotech giant Bristol Myers (BMY) outperforms the industry and the S&P 500 Index as Eliquis and Opdivo maintain momentum despite generic competition for Revlimid.
2 Stocks to Buy Whether or Not a Recession Is Coming
09:37am, Friday, 18'th Nov 2022
Both have outperformed the stock market this year.
Bristol-Myers Squibb Company (BMY) Presents at 4th Annual Wolfe Research Healthcare Conference (Transcript)
05:59pm, Wednesday, 16'th Nov 2022
Bristol-Myers Squibb Company (NYSE:BMY ) 4th Annual Wolfe Research Healthcare Conference November 16, 2022 3:20 PM ET Company Participants Chris Boerner - EVP and Chief Commercialization Officer Confe
